SCHEMBL9379944

SCHEMBL9379944

CC1(C)CC(=O)C2=C(N1)c1[nH]c(-c3ccc(S(=O)(=O)O)cc3)nc1CC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 7/20 0.38
▸ ADORA2A P29274 5/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ GLA P06280 3/20 0.38
▸ HPGD P15428 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ ADORA3 P0DMS8 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ WNT3A P56704 6/20 0.38
▸ TNKS2 Q9H2K2 6/20 0.38
▸ MEN1 O00255 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ CYP2D6 P10635 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.34
▸ ENPP2 Q13822 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9380207 0.87 TNKS2 (0.36) ADORA2BADORA2AWNT3ATNKS2
SCHEMBL9378641 0.85 TNKS2 (0.42) ALDH1A1HPGDWNT3ATNKS2MEN1
SCHEMBL9379011 0.85 TNKS2 (0.36) ADORA2BKDM4EALDH1A1GLAHPGD
SCHEMBL9378262 0.85 KMT2A (0.38) ADORA2BKDM4EALDH1A1HPGDTNKS2
SCHEMBL9385136 0.84 BRAF (0.35) WNT3ATNKS2
SCHEMBL9382394 0.84 WNT3A (0.36) WNT3ATNKS2
SCHEMBL9379363 0.84 IDO1 (0.39) ALDH1A1HPGDHSD17B10ADORA1ALOX15
SCHEMBL9377862 0.83 CHEK2 (0.38) ADORA2BADORA2AWNT3ATNKS2
SCHEMBL9379057 0.79 BUB1 (0.35) —
SCHEMBL9381718 0.77 ADH5 (0.43) CYP2C19TSHRCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0275888-B1 Tricyclic benzimidazoles, process for their preparation and use as medicaments BOEHRINGER MANNHEIM GMBH (DE) 1994-04-06 — — EP disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 — — EP disclosed
Send feedback